Methotrexate 50mg/2mL
| Product Overview | |
| Generic Name | Methotrexate 50mg/2mL |
| Brand Name(s) | Rheumatrex, Trexall |
| Form | intravenous/intramuscular/subcutaneous injection |
| Strength | 50 mg/2 mL |
| Therapeutic Class | Antimetabolite; folic acid analogue with immunosuppressant & antineoplastic activity |
| ATC Code | L01BA01 |
| Manufacturing & Regulatory | |
| Manufacturer | Actavis, Teva |
| GMP Compliance | WHO-GMP certified |
| DMF/CEP | Type II |
| COFEPRIS | Batch-specific |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 100 units |
| Shelf Life | 36 months |
| Storage | 2–8 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes |
